Clinical Trials Directory

Trials / Completed

CompletedNCT02224014

Lendormin D® Tablet (Drug Use Result Survey)

Status
Completed
Phase
Study type
Observational
Enrollment
485 (actual)
Sponsor
Boehringer Ingelheim · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Study to investigate the safety and the efficacy in patients with insomnia, receiving Lendormin D tablet under condition of normal clinical practice.

Conditions

Interventions

TypeNameDescription
DRUGLendormin D tablets

Timeline

Start date
2005-06-01
Primary completion
2006-03-01
First posted
2014-08-22
Last updated
2014-08-22

Source: ClinicalTrials.gov record NCT02224014. Inclusion in this directory is not an endorsement.